接受经导管缘对缘修复的心房功能性二尖瓣反流亚型:心房源性牵制型疗效欠佳
在1047例连续接受二尖瓣经导管缘对缘修复的患者中,128例(12.2%)符合心房功能性二尖瓣反流标准,分为单纯瓣环扩张型(AFMR-IAD,75例,58.6%)和心房源性牵制型(AFMR-AH,53例,41.4%)。AFMR-AH的技术成功率低于AFMR-IAD(86.8% vs 98.7%,P=0.009),30天和1年MR≤II比例均更低,且与30天手术失败和1年全因死亡相关。作者结论认为AFMR-AH行M-TEER的结局劣于AFMR-IAD,需对该病理保持警惕并可能需考虑替代二尖瓣治疗方式。
要点
- AFMR-AH表现为后叶运动受限(Carpentier IIIb),技术成功率86.8%低于AFMR-IAD的98.7%(P=0.009)。
- 出院时器械脱落仅见于AFMR-AH,发生率为10.0%。
- AFMR-AH的1年全因死亡风险高于AFMR-IAD(HR 2.54,95%CI 1.09-5.91,P=0.031)。
核心结论
- AFMR-AH接受M-TEER后的手术和临床结局均劣于AFMR-IAD,作者认为应对该病理保持警惕并可能需考虑替代二尖瓣治疗方式。
研究设计与样本
- 研究为单中心连续病例分析,共纳入1047例接受M-TEER的患者,其中128例(12.2%)符合AFMR标准,按超声特征分为AFMR-IAD(75例,58.6%)和AFMR-AH(53例,41.4%),分析基线超声特征及至1年的结局。
关键影像表现/征象
- AFMR-AH较AFMR-IAD表现为更大的左房和左室容积、更大的二尖瓣环、更短且更陡的后叶以及更严重的MR(均P<0.05)。
- 出院时器械脱落仅见于AFMR-AH,发生率为10.0%。
诊断标准与关键数值
- AFMR-IAD定义为单纯二尖瓣环扩张(Carpentier I型)。
- AFMR-AH定义为以限制性后叶运动为特征的心房源性牵制(Carpentier IIIb型)。
- 技术成功率AFMR-IAD为98.7%、AFMR-AH为86.8%(P=0.009)。
- MR≤II在30天时AFMR-IAD为95.6%、AFMR-AH为78.6%(P=0.009),1年时分别为93.0%和74.1%(P=0.038)。
临床应用与阅片要点
- AFMR-AH在30天手术失败率为43.4%,AFMR-IAD为24.0%(P=0.023),OR 1.17(95%CI 1.00-1.38,P=0.045)。
- 1年全因死亡AFMR-AH为77%、AFMR-IAD为92%(Kaplan-Meier估计1年生存率,P=0.017),HR 2.54(95%CI 1.09-5.91,P=0.031)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Two subtypes of atrial functional mitral regurgitation (AFMR) have been described, one is characterized by Carpentier type I and the other by Carpentier type IIIb leaflet motion.
OBJECTIVES: The authors sought to analyze echocardiographic characteristics and outcomes of AFMR subtypes undergoing mitral valve transcatheter edge-to-edge repair (M-TEER).
METHODS: Of 1,047 consecutive patients who underwent M-TEER, the authors identified those with isolated mitral annulus dilation (Carpentier I), termed AFMR-IAD, and those with atriogenic hamstringing characterized by restricted posterior mitral leaflet motion (Carpentier IIIb), termed AFMR-AH. Echocardiographic baseline characteristics and outcomes up to 1-year were analyzed.
RESULTS: A total of 128 patients (12.2%) met AFMR criteria; 75 (58.6%) were identified as AFMR-IAD and 53 (41.4%) as AFMR-AH. AFMR-AH displayed greater left atrial and left ventricular volumes, greater mitral annulus, shorter and steeper posterior mitral leaflet, and more pronounced MR (all P < 0.05). Technical success was achieved in 98.7% (AFMR-IAD) and 86.8% (AFMR-AH) of patients (P = 0.009). At discharge, device detachments were exclusively observed in AFMR-AH (10.0%). MR ≤II was achieved in 95.6% and 78.6% at 30 days (P = 0.009) and in 93.0% and 74.1% at 1 year (P = 0.038) in patients with AFMR-IAD and AFMR-AH, respectively. AFMR-AH was associated with procedural failure (OR: 1.17 [95% CI: 1.00-1.38]; P = 0.045) at 30 days (43.4% vs 24.0%; P = 0.023) and all-cause mortality (HR: 2.54 [95% CI: 1.09-5.91]; P = 0.031) at 1 year (77% vs 92%, Kaplan-Meier estimated 1-year survival; P = 0.017).
CONCLUSIONS: AFMR-AH shows worse procedural and clinical outcomes following M-TEER than AFMR-IAD. Thus, vigilance regarding this pathology is warranted and alternative mitral valve therapies might need to be considered.
引用
- von Stein P, von Stein J, Hohmann C, et al. Atrial Functional Mitral Regurgitation Subtypes Undergoing Transcatheter Edge-to-Edge Repair: Suboptimal Outcomes in Atriogenic Hamstringing. JACC Cardiovasc Imaging. 2024. PMID: 39207336. doi:10.1016/j.jcmg.2024.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。